AnaptysBio (ANAB) vs. PTCT and MIRM: Is the Market Missing the Value of Its Royalty Stream and Legal Upside?

Is ANAB a good stock to buy? We came across a bullish thesis on AnaptysBio, Inc. on TripleS Special Situations’s Substack. Since the thesis was published on June 15^th, ANAB shares have pulled back as uncertainty over its GSK dispute and scrutiny of earnings boosted by a one-time tax benefit weighed on sentiment, creating a near-term hurdle after its standout run.  In this article, we will summarize the bulls’ thesis on ANAB. AnaptysBio, Inc.’s share was trading at $48.64 as of October...